Publication

publication source image
Adverse Events Reported During Weekly Isoniazid-Rifapentine (3HP) Tuberculosis Preventive Treatment Among People With Human Immunodeficiency Virus in Uganda
Kadota JL, Musinguzi A, Aschmann HE, et al.
Read more